An implantable MEMS drug delivery device for rapid delivery in ambulatory emergency care

We introduce the first implantable drug delivery system based on MEMS (Micro-Electro-Mechanical-Systems) technology specifically designed as a platform for treatment in ambulatory emergency care. The device is named IRD3 (implantable rapid drug delivery device) and allows rapid delivery of drugs. Vasopressin was used as a model drug for in vitro tests as it is a commonly used drug for cardiac resuscitation. Experimental results reveal that the IRD3 provides an effective method for rapid delivery without significant drug degradation. Several medical uses and delivery modalities for IRD3 are proposed.

[1]  B. Lindsay,et al.  Implantable cardioverter-defibrillator therapy improves long-term survival in patients with unexplained syncope, cardiomyopathy, and a negative electrophysiologic study. , 2005, Heart rhythm.

[2]  H. Edmonds,et al.  Head‐up Tilt Testing Predicts Syncope During Ventricular Tachycardia in Implantable Cardioverter Defibrillator Patients , 1998 .

[3]  John T Santini,et al.  Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device , 2006, Nature Biotechnology.

[4]  L. Mont,et al.  Incidence of syncope after ICD implantation: low or high? , 2006, European heart journal.

[5]  Michael J Cima,et al.  Microchip technology in drug delivery , 2000, Annals of medicine.

[6]  Robert Langer,et al.  Application of Micro- and Nano-Electromechanical Devices to Drug Delivery , 2006, Pharmaceutical Research.

[7]  Robert Langer,et al.  Multi-pulse drug delivery from a resorbable polymeric microchip device , 2003, Nature materials.

[8]  Slava Krylov,et al.  Multiple aspect-ratio structural integration in single crystal silicon (MASIS) for fabrication of transmissive MOEMS modulators , 2007 .

[9]  R Langer,et al.  Microchips as Controlled Drug-Delivery Devices. , 2000, Angewandte Chemie.

[10]  John T Santini,et al.  Electrothermally activated microchips for implantable drug delivery and biosensing. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Robert Langer,et al.  Size and temperature effects on poly(lactic-co-glycolic acid) degradation and microreservoir device performance. , 2005, Biomaterials.

[12]  G. Kotzar,et al.  Evaluation of MEMS materials of construction for implantable medical devices. , 2002, Biomaterials.

[13]  W. Aronow.  Treatment of unstable angina pectoris/non-ST-segment elevation myocardial infarction in elderly patients. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

[14]  Rebecca S. Shawgo,et al.  Biocompatibility and biofouling of MEMS drug delivery devices. , 2003, Biomaterials.

[15]  M. Einarson.  Controlled-release microchip , 1999, Nature Biotechnology.

[16]  J. Maibach,et al.  A new analytical solution for the load-deflection of square membranes , 1995 .

[17]  Nam-Trung Nguyen,et al.  MEMS-Micropumps: A Review , 2002 .

[18]  G. Fonarow,et al.  Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator. , 2000, The American journal of cardiology.